Evidence map›Paper›PMID 38086993›Full record

ArticleCancer gene therapy2024

SPRTN is involved in hepatocellular carcinoma development through the ER stress response.

Anja Batel, Mirjana Polović, Mateo Glumac, Oliver Šuman, Stipislav Jadrijević, Bernarda Lozić, Marija Petrović, Bobana Samardžija, Nicholas J Bradshaw, Karlo Skube and 3 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Anja Batel *Laboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Mirjana Polović *Laboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Mateo Glumac *Laboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Oliver ŠumanDepartment of Abdominal Surgery, Merkur Clinical Hospital, Zajčeva 19, 10000, Zagreb, Croatia.
Stipislav JadrijevićDepartment of Abdominal Surgery, Merkur Clinical Hospital, Zajčeva 19, 10000, Zagreb, Croatia.
Bernarda LozićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Marija PetrovićLaboratory for Human Genetics, University Hospital Split, Spinčićeva 1, 21000, Split, Croatia.
Bobana SamardžijaFaculty of Biotechnology & Drug Development, University of Rijeka, Radmile Matejčić 2, 51000, Rijeka, Croatia.
Nicholas J BradshawFaculty of Biotechnology & Drug Development, University of Rijeka, Radmile Matejčić 2, 51000, Rijeka, Croatia.ORCID 0000-0001-5581-8828
Karlo SkubeSelvita, Prilaz baruna Filipovića 29, 10000, Zagreb, Croatia.
Vinko PaladaDepartment of Physiology, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Mislav AcmanOmics solutions, trg 101. Brigade HV 1, 10000, Zagreb, Croatia.
Ivana Marinović TerzićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia. ivana.marinovic.terzic@mefst.hr.ORCID 0000-0003-1109-4682
University of Split · HRKlinička bolnica Merkur · HRUniversity of Rijeka · HRPliva (Croatia) · HRUniversity of Helsinki · FI

Funding

Hrvatska Zaklada za Znanost (Croatian Science Foundation) IP-2016-06-3097
6 · The paper itself

Abstract

Endoplasmic reticulum (ER) stress, prompted by the accumulation of misfolded or unfolded proteins, triggers the activation of the unfolded protein response (UPR) pathway to restore ER homeostasis. This stress response is implicated in the development of hepatocellular carcinoma (HCC). A biallelic mutation in SPRTN is currently the only known single-gene mutation implicated in the early onset of HCC. However, the exact mechanism linking SPRTN mutations to HCC remains unclear. In our study, we analyzed SPRTN and UPR in 21 human HCC tissue samples using RT-qPCR, immunoblot, and immunohistochemistry. We found alterations in the expression levels of SPRTN and UPR-related genes and proteins in HCC samples. The impact of SPRTN on the ER stress response was assessed in SPRTN-depleted HepG2 cells through RNA sequencing, pull-down assay, comet assay, and mitotic index calculation. We demonstrated that SPRTN interacts with the UPR sensor GRP78. Furthermore, we observed a decrease in SPRTN levels during ER stress, and increased sensitivity to ER stress in SPRTN-depleted cells. These findings suggest an essential role for SPRTN in the ER stress response and provide new insights into HCC pathogenesis. This newly discovered function of SPRTN could significantly enhance our understanding and treatment of HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsDNA-Binding ProteinsEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressHumansUnfolded Protein ResponseDNA-Binding ProteinsEndoplasmic Reticulum Chaperone BiPSPRTN protein, human

Identifiers

PMID38086993
OpenAlexW4389648923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.